Company
Last deal
$55.6M
Local Amount - CNY 400M
Amount
Series C
Stage
02.08.2023
Date
3
all rounds
$76.1M
Total amount
General
About Company
GeneMind Biosciences is a third-generation gene sequencing system.
Industry
Sector :
Subsector :
Also Known As
GeneMind, Zhenmai Bio
founded date
01.01.2012
Company Type
For Profit
Last funding type
Series C
IPO status
Private
Contacts
Phone number
Website URL